The exploration of novel therapeutic target in gastric cancer by comprehensive tyrosine-kinase analysis
Project/Area Number |
23591930
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Osaka University |
Principal Investigator |
YAMASAKI Makoto 大阪大学, 医学(系)研究科(研究院), 助教 (50444518)
|
Co-Investigator(Kenkyū-buntansha) |
TAKIGUCHI Shuuji 大阪大学, 医学部付属病院消化器外科, 講師 (00301268)
MIYATA Hiroshi 大阪大学, 医学部付属病院消化器外科, 講師 (80362713)
KUROKAWA Yukinori 大阪大学, 医学部付属病院消化器外科, 助教 (10470197)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Keywords | 胃癌 / チロシンキナーゼ / 腹膜播種 / 網羅的発現解析 / 化学療法感受性 |
Research Abstract |
We analyzed the comprehensive gene expression in gastric cancer to explore the novel tyrosine-kinase related to the development of cancer, especially peritoneal dissemination. Then the novel and well-known tyrosine-kinases; KSR1 and MEK, Her2 and FGFR1 were identified. KSR1 is a tyrosine-kinase that functions as positive regulator of Ras pathway, and associated with the cell motility, invasion and peritoneal dissemination. FOXM1, DOK2 and REGIV are identified as the downstream molecules of the tyrosine-kinases, MEK, Her2 and FGFR1, respectively in consequence of the analysis of the correlativity between the pathways of these tyrosine-kinases and gene expression analysis. It was shown that these molecules related with the prognosis, peritoneal dissemination and the sensitivity of anticancer drug. This result may enable us to elucidate the signaling related to the biological character of gastric cancer and develop the novel molecular-targeted agent.
|
Report
(4 results)
Research Products
(6 results)
-
[Journal Article] Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer2013
Author(s)
Okada K, Fujiwara Y, Takahashi T, Nakamura Y, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y.
-
Journal Title
Ann Surg Oncol
Volume: 20(3)
Pages: 1035-43
Related Report
-
[Journal Article] Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer2013
Author(s)
Okada Kaoru, Fujiwara Yosiyuki, Takahashi Tsuyoshi, Nakamura Yusuke, Takiguti Syuji, Nakajima Kiyokazu, Miyata Hiroshi, Yamasaki Makoto, Kurokawa Yukinori, Mori Masaki,and Doki Yuichiro
-
Journal Title
Annals of Surgical Oncology
Volume: 20
Issue: 3
Pages: 1035-1043
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma2012
Author(s)
Moon JH, Fujiwara Y, Nakamura Y, Okada K, Hanada H, Sakakura C, Takiguchi S, Nakajima K, Miyata H, Yamasaki M, Kurokawa Y, Mori M, Doki Y.
-
Journal Title
J Surg Oncol
Volume: 105(2)
Pages: 189-94
Related Report
-
-